CompanyGraph
What stands out
- Most companies in its industry are risk businesses; this one is a production business
At a glance
- Depends onUpstream position: supplies 3 industries, depends on 0
- ScaleRevenue is $701,967, lower than 95% of all stocks globally
- PositionReturn on equity is 2273.7%, higher than 95% of its Shell Companies peers (median 2.3%)
- Interpretations2 currently firing — 2
What this company is and how it runs — written from structure, not news.
What stands out
- Most companies in its industry are risk businesses; this one is a production business
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
The statements on file don't all cover the same year: income statement FY2024, balance sheet FY2025, cash-flow statement FY2024. Each figure below is labelled with the year it comes from.
Financials view
Market Capitalization
1.69BUSDvs all stocks (USD)
Revenue (TTM)
701.97KUSDvs all stocks (USD)
52-Week Change
-59.20%vs all stocks
Market Capitalization
1.69BUSDvs all stocks (USD)
Enterprise Value
1.69BUSDvs all stocks (USD)
Price to Book (MRQ)
0.5589xvs Shell Companies peers
Enterprise to Revenue
2.41KxEnterprise to EBITDA
-35.36xvs Shell Companies peers
Gross Margin
26.84%Return on Assets (TTM)
-673.30%vs Shell Companies peers
Return on Equity (TTM)
2273.74%Revenue (TTM)
701.97KUSDvs all stocks (USD)
Revenue per Share (TTM)
0.4513USDUpdated Jul 19, 2026Quarterly Revenue Growth
4402.76%Gross Profit (TTM)
-2.45MUSDvs all stocks (USD)
EBITDA (TTM)
0.00USDvs all stocks (USD)
Net Income (TTM)
-49.41MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
1736.36%vs Shell Companies peers
Operating Cash Flow (TTM)
-34.57MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-49.41MUSDvs all stocks (USD)
Revenue
701.97KUSDFY2024 · Dec 31, 2024Cost of Goods Sold
3.15MUSDFY2024 · Dec 31, 2024Gross Profit
-2.45MUSDFY2024 · Dec 31, 2024Operating Income
-42.06MUSDvs all stocks (USD)
Pre-tax Income
-48.41MUSDFY2024 · Dec 31, 2024Net Income
-49.41MUSDFY2024 · Dec 31, 2024EBIT
-48.24MUSDFY2024 · Dec 31, 2024EBITDA (Income Statement)
-47.81MUSDFY2024 · Dec 31, 2024Selling, General & Administrative
39.61MUSDFY2024 · Dec 31, 2024Non-operating Interest Income
57.60KUSDFY2024 · Dec 31, 2024Non-operating Interest Expense
175.93KUSDFY2024 · Dec 31, 2024EPS (Basic)
-31.85USDFY2024 · Dec 31, 2024EPS (Diluted)
-31.85USDFY2024 · Dec 31, 2024Basic Shares Outstanding
1.56MSharesFY2024 · Dec 31, 2024Diluted Shares Outstanding
1.56MSharesFY2024 · Dec 31, 2024Operating Cash Flow
-34.57MUSDFY2024 · Dec 31, 2024Free Cash Flow
-34.65MUSDFY2024 · Dec 31, 2024Cash & Cash Equivalents (End of Period)
348.82KUSDFY2024 · Dec 31, 2024Starting Profit (CF Statement)
-48.41MUSDFY2024 · Dec 31, 2024Depreciation & Amortization
428.83KUSDFY2024 · Dec 31, 2024Stock-based Compensation
5.12MUSDFY2024 · Dec 31, 2024Other Non-cash Items
7.39MUSDFY2024 · Dec 31, 2024Change in Accounts Receivable (CF)
-367.30KUSDFY2024 · Dec 31, 2024Change in Accounts Payable (CF)
725.00KUSDFY2024 · Dec 31, 2024Change in Other Assets/Liabilities
549.07KUSDFY2024 · Dec 31, 2024Capital Expenditures
-85.67KUSDFY2024 · Dec 31, 2024Net Intangibles (CF)
417.44KUSDFY2024 · Dec 31, 2024Net Acquisitions
0.00USDFY2024 · Dec 31, 2024Purchase of Investments
-739.56KUSDFY2024 · Dec 31, 2024Sale of Investments
490.00KUSDFY2024 · Dec 31, 2024Other Investing Activity
-87.16KUSDFY2024 · Dec 31, 2024Net Investing Cash Flow
-422.38KUSDFY2024 · Dec 31, 2024Long-term Debt Issuance
0.00USDFY2024 · Dec 31, 2024Long-term Debt Payments
0.00USDFY2024 · Dec 31, 2024Other Financing Charges
943.72KUSDFY2024 · Dec 31, 2024Net Financing Cash Flow
15.53MUSDFY2024 · Dec 31, 2024Shares Outstanding
4.90MSharesUpdated Jul 19, 2026Total Cash (MRQ)
8.96MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.09USDUpdated Jul 19, 2026Total Debt (MRQ)
381.50KUSDvs all stocks (USD)
Current Ratio (MRQ)
10.59xvs Shell Companies peers
Book Value per Share (MRQ)
17.59USDUpdated Jul 19, 2026Total Assets
140.01KUSDvs all stocks (USD)
Total Current Assets
30.00KUSDFY2025 · Dec 31, 2025Total Liabilities
130.44KUSDFY2025 · Dec 31, 2025Total Non-current Assets
110.01KUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
-200.00USDFY2025 · Dec 31, 2025Total Current Liabilities
130.64KUSDFY2025 · Dec 31, 2025Short-term Debt
40.42KUSDFY2025 · Dec 31, 2025Common Stock (Book)
767.00USDFY2025 · Dec 31, 2025Retained Earnings
-15.63KUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
9.57KUSDvs all stocks (USD)
52-Week Low
1.14USDUpdated Jul 19, 202652-Week High
46.90USDUpdated Jul 19, 202652-Week Change
-59.20%vs all stocks
50-Day MA
0.00USDUpdated Jul 19, 2026200-Day MA
0.00USDUpdated Jul 19, 2026Avg 10-Day Volume
113.11KSharesUpdated Jul 19, 2026Avg 30-Day Volume
477.34KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-31.85USDUpdated Jul 19, 2026Other Income / Expense
-6.24MUSDFY2024 · Dec 31, 20242 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 2273.7%, higher than 95% of its Shell Companies peers (median 2.3%)Significant
Return on equity: 22.74Industry median: 0.02Industry P95: 0.04Peers compared: 70.00
Return on assets is -673.3%, lower than 95% of its Shell Companies peers (median 2.2%)Significant
Return on assets: -6.73Industry median: 0.02Industry P5: -0.04Peers compared: 70.00
Structural Tensions
Most companies in its industry are risk businesses; this one is a production businessSignificant
Industry peers: 62.00Share on the common pattern %: 76.00
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.50
Supply Chain
Upstream position: supplies 3 industries, depends on 0Notable
Outgoing: 3.00Incoming: 0.00
Scale
Revenue is $701,967, lower than 95% of all stocks globallySignificant
Revenue (USD): 701,967Global P5: 30,274,777.221
Market cap is $1.69B, above the global median of $1.15BNotable
Market cap (USD): 1,685,272,156Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Cofoe Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Alivus Life Sciences Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Shyndec Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Ningbo Menovo Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
PolyPeptide Group AG
Tier 1ProductionApproval-Gated PipelineRuleFlow
Green Thumb Industries Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
OneSource Specialty Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Novocure Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hunan Jingfeng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Yifan Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Nusantara Sawit Sejahtera Tbk
2 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Pim Korea Co., Ltd.
2 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Ecopro Materials Co., Ltd.
2 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated